197067530	197067530	CD	B-NP	O
|	|	NN	I-NP	O
SVH	SVH	NN	I-NP	O
|	|	NN	I-NP	O
20930664	20930664	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0480049	0480049	CD	B-NP	O
|	|	CC	I-NP	O
1/10/2003	1/10/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Congestive	Congestive	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/21/2003	2/21/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/26/2003	4/26/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MAUSETH	MAUSETH	NN	B-NP	O
,	,	,	O	O
STEVIE	STEVIE	NN	B-NP	O
657-85-93-4	657-85-93-4	CD	I-NP	O
Dar	Dar	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/10/03	6/10/03	CD	B-NP	O
AT	AT	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DOMINQUEZ	DOMINQUEZ	NNP	B-NP	O
,	,	,	O	O
JON	JON	NNP	B-NP	O
DERRICK	DERRICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	B-protein
200	200	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/5/03	11/5/03	CD	B-NP	O
by	by	IN	B-PP	O
PIRILLO	PIRILLO	NNP	B-NP	O
,	,	,	O	O
VIRGIL	VIRGIL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
LAC-HYDRIN	LAC-HYDRIN	NN	I-NP	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
AMMONIUM	AMMONIUM	NN	I-NP	O
LACTATE	LACTATE	NN	I-NP	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
LE	LE	NN	B-NP	B-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/5/03	11/5/03	CD	B-NP	O
by	by	IN	B-PP	O
ANDRAE	ANDRAE	NNP	B-NP	O
,	,	,	O	O
NEIL	NEIL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
gluburide	gluburide	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/5/03	11/5/03	CD	B-NP	O
by	by	IN	B-PP	O
STROOP	STROOP	NN	B-NP	O
,	,	,	O	O
CARROL	CARROL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
PLAQUENIL	PLAQUENIL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROXYCHLOROQUINE	HYDROXYCHLOROQUINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-protein
ISORDIL	ISORDIL	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	I-protein
DINITRATE	DINITRATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NITROGLYCERIN	NITROGLYCERIN	NNP	I-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
0.4	0.4	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
SARNA	SARNA	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
QD	QD	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
WARFARIN	WARFARIN	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
mwfsun	mwfsun	NN	I-NP	O
;	;	:	O	O
2.5	2.5	CD	B-NP	O
MG	MG	NN	I-NP	O
ttsat	ttsat	NN	I-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
mwfsun	mwfsun	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
ttsat	ttsat	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
QHS	QHS	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/5/03	11/5/03	CD	B-NP	O
by	by	IN	B-PP	O
TINES	TINES	NN	B-NP	B-protein
,	,	,	O	O
SCOTT	SCOTT	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AMIODARONE	AMIODARONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
78104851	78104851	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/10/03	6/10/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POSSIBLE	POSSIBLE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
taking	take	VBG	B-VP	O
without	without	IN	B-PP	O
problems	problem	NNS	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Call	Call	VB	B-VP	O
498-674-2301	498-674-2301	CD	B-NP	O
for	for	IN	B-PP	O
appt	appt	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stickman	Stickman	NNP	I-NP	O
or	or	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Wiedman	Wiedman	NNP	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
9/29/03	9/29/03	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
TIHASCOCK	TIHASCOCK	NN	B-NP	O
UNIVERSITY	UNIVERSITY	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Sotalol	Sotalol	NN	B-NP	O
,	,	,	O	O
Procainamide	Procainamide	NNP	B-NP	O
,	,	,	O	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Quinaglute	Quinaglute	NNP	B-NP	O
,	,	,	O	O
Asa	Asa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
Heart	Heart	NN	I-NP	O
Failure	Failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Congestive	Congestive	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
CHF	CHF	NN	I-NP	O
s/p	s/p	NN	I-NP	O
St.	St.	NNP	I-NP	O
Jude	Jude	NNP	I-NP	O
MVR	MVR	NNP	I-NP	O
for	for	IN	B-PP	O
MS	MS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
AFib/flutter	AFib/flutter	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
H/O	H/O	NNP	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
IMI	IMI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
Hx	Hx	NN	I-NP	O
DVT	DVT	NN	I-NP	O
'70	'70	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appy	appy	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
sigmoidectomy	sigmoidectomy	NN	I-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
L	L	NN	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
'95	'95	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
S/P	S/P	NN	I-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PE	PE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
80	80	CD	B-NP	O
yo	yo	NN	I-NP	O
lady	lady	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
IMI	IMI	NN	B-NP	B-protein
,	,	,	I-NP	O
MVR	MVR	NN	I-NP	B-protein
,	,	,	I-NP	O
Afib	Afib	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
DOE	DOE	NNP	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
lasix	lasix	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
in	in	IN	B-PP	O
DYAN	DYAN	NN	B-NP	O
MEMORIAL	MEMORIAL	NN	I-NP	O
HEALTH	HEALTH	NN	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
for	for	IN	B-PP	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
-	-	HYPH	B-NP	O
LENIS	LENIS	NN	I-NP	B-protein
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
PO	PO	NN	B-NP	O
levo	levo	NN	I-NP	O
.	.	.	O	O

Presents	Present	NNS	B-NP	O
in	in	IN	B-PP	O
DUNBRID	DUNBRID	NN	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
today	today	NN	B-NP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
LE	LE	NN	I-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	I-NP	O
tightness	tightness	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
on	on	IN	B-PP	O
waking	wake	VBG	B-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
last	last	JJ	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

Associated	Associate	VBN	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
relieved	relieve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
with	with	IN	B-PP	O
with	with	IN	B-PP	O
SLNGT	SLNGT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
-	-	HYPH	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

RR	RR	NN	B-NP	B-protein
14	14	CD	I-NP	I-protein
RA	RA	NN	I-NP	I-protein
sat	sit	VBD	B-VP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2l	2l	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

CVS	CVS	NN	B-NP	B-protein
-	-	HYPH	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
mi	mi	NNS	B-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
and	and	CC	I-NP	O
EKGs	EKG	NNS	I-NP	B-protein
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
,	,	,	O	O
isordil	isordil	NN	B-NP	O
and	and	CC	I-NP	O
norvasc	norvasc	NN	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
level	level	NN	I-NP	I-protein
135	135	CD	I-NP	I-protein
.	.	.	O	O

Diuresed	Diurese	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	O	O
converted	convert	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
po	po	VB	I-VP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
-	-	HYPH	B-ADJP	O
in	in	IN	B-PP	O
Afib	Afib	NNP	B-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
exacerbation	exacerbation	NN	B-NP	O
.	.	.	O	O

Well	Well	RB	B-ADVP	O
controlled	control	VBN	B-VP	O
on	on	IN	B-PP	O
amio	amio	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
cont	cont	NN	I-NP	O
couamdin	couamdin	NN	I-NP	O
,	,	,	O	O
LENIs	LENI	NNS	B-NP	B-protein
done	do	VBN	B-VP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
neg	neg	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
-	-	HYPH	O	O
changed	change	VBN	B-VP	O
glyburide	glyburide	NN	B-NP	O
to	to	TO	B-VP	O
glipizide	glipizide	VB	I-VP	O
for	for	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	O
clearance	clearance	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

RENAL	RENAL	JJ	B-NP	O
-	-	HYPH	I-NP	O
creatinine	creatinine	NN	I-NP	O
stable	stable	JJ	I-NP	O
-	-	HYPH	I-NP	O
follow	follow	NN	I-NP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
has	have	VBZ	B-VP	O
restrictive	restrictive	JJ	B-NP	O
pattern	pattern	NN	I-NP	O
on	on	IN	B-PP	O
PFTs	PFT	NNS	B-NP	B-DNA
,	,	,	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
outpt	outpt	JJ	B-NP	O
CT	CT	NN	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
with	with	IN	B-PP	O
appt	appt	NN	B-NP	O
time	time	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
next	next	JJ	I-NP	O
test	test	NN	I-NP	O
-	-	HYPH	O	O
called	call	VBN	B-VP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Go	Go	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
next	next	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
test	test	NN	I-NP	O
tentatively	tentatively	RB	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
11/9/03	11/9/03	CD	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
notified	notify	VBN	I-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
Call	Call	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
ambulance	ambulance	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
sudden	sudden	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Clemence	Clemence	NNP	I-NP	O
after	after	IN	B-PP	O
your	your	PRP$	B-NP	O
test	test	NN	I-NP	O
next	next	IN	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SHAUER	SHAUER	NNP	B-NP	O
,	,	,	O	O
DEVON	DEVON	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SX532	SX532	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/10/03	6/10/03	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

